
|Articles|May 1, 2003
- Pharmaceutical Executive-05-01-2003
Table of Contents
Table of Contents
Advertisement
Articles in this issue
almost 23 years ago
E-Learning FDA Stylealmost 23 years ago
Patient Data Come of Agealmost 23 years ago
What's Really Driving Costs?almost 23 years ago
Fourth Annual Pharm Exec 50almost 23 years ago
The Riddle of RiskNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $8.5 Billion Strategic Collaboration with Innovent Biologics and Acquires Orna Therapeutics
2
Pharma Funding Roundup: QuantX Biosciences, Pandorum Technologies Complete Series B Financing Rounds
3
Articulating the Long-Term Value of AI-Powered Approaches
4
Bets and Balances: Riding the Risk-and-Innovation Pendulum in Biotech
5




